Dr. Cheung Explains Focused Heat Treatment for Cancer
In a recent video, Dr. Augustine Y. Cheung, president and CEO of Medifocus Inc., explains the focus of his company on tumor treatment. Medifocus Inc. develops and commercializes minimally invasive treatment systems for malignant and benign tumors, specifically in breast and prostate cancers. The Adaptive Phased Array (APA)-1000 precisely focuses and controls microwave energy to shrink breast cancer tumors without side-effects. For prostate cancer, the Prolieve® System is based on endo-thermotherapy that dilates the prostatic urethra and heats the prostate. Cheung says his vision is to be...
Read MoreProlieve Offers 45-Minute Procedure for BPH Relief
In a recent video interview with Bob Giordano, President and CEO of Medifocus Dr. Augustine Y. Cheung explains how his Prolieve BPH Treatment works. Bob Giordano is a Principal at Launchpad IR. He has worked in the financial services industry for 35 years and was originally trained to be a lawyer. He worked with investor relations, focusing on emerging small cap mineral resource and life sciences companies. Benign Prostatic Hyperplasia (BPH) is a non-cancerous urological disease in which the prostate (a walnut-sized gland that preserves and transports seminal fluid and sperm) enlarges and...
Read MoreDr. Augustine Y. Cheung Explains Medifocus’ APA-1000 System in a New Video Interview
A recent video interview with Augustine Y. Cheung, PhD, President and CEO of Medifocus, explains how the company’s technology can help women with breast cancer. By offering targeted heat treatment for breast cancer, Medifocus’ technology can shrink tumors up to 8 cm in size to small enough to be removed with a lumpectomy. The equipment, known as the Adaptive Phased Array (APA)-1000 system, has received regulatory approvals from the FDA to conduct the Phase III trials necessary for marketing the system. A lumpectomy represents a better chance for a woman to keep her breasts over...
Read MoreThe Prolieve® Thermodilatation System
The Prolieve System Website The Prolieve system provides a 45-minute in-office treatment that combines our microwave thermotherapy capability with a proprietary balloon compression technology to both heat the prostate and dilate the prostatic urethra. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy and certain types of surgical procedures to treat the symptoms of BPH.
Read MoreRaising the standards of care
With our proprietary focused heat technology platforms, our treatments are minimally invasive, non-toxic. We are leading the way in new developments in cancerous and non-cancerous treatments for breast disease and BPH.
Read MoreImprove the Outcome
Our goal is to improve outcomes and standards of care in cancerous and non-cancerous treatments. Clinical studies have demonstrated that when used in conjunction with chemotherapy for breast cancer, Medifocus’ patented APA system can significantly increase tumor shrinkage by 50 percent. For BPH, the Prolieve system has shown it can significantly decrease the American Urological Association (AUA) symptom scores.
Read MoreMedical Professionals
Medifocus develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The Company owns two technology platforms with comprehensive US and international patent protection: 1. The “Endo-thermotherapy Platform”, and 2. The “Adaptive Phased Array Microwave Focusing Platform”. The Company has received regulatory approvals to complete the APA 1000’s pivotal Phase-III clinical trials, the final step before marketing approval. The U.S....
Read MoreMinimally Invasive
Our focused heat treatment systems are designed with patients’ needs and comfort in mind. They are minimally invasive, nontoxic, and have little to no side effects.
Read MoreBetter Cancer Treatment Options
The future goal for Medifocus is to further expand the capabilities of its APA microwave focusing technology platform to develop and commercialize other focused heat treatment systems for surface, subsurface and deep seated tumors anywhere in the body.
Read More